Dalazatide
- Generic Name
- Dalazatide
Multiple Ascending Dose Safety Study of ShK-186 (Dalazatide) in Healthy Volunteers
- First Posted Date
- 2015-05-18
- Last Posted Date
- 2015-05-18
- Lead Sponsor
- Kineta Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT02446340
- Locations
- 🇺🇸
PRA International, Lenexa, Kansas, United States
A 4 Week Study of the Safety, Tolerability, and Pharmacodynamics of ShK-186 (Dalazatide) in Active Plaque Psoriasis
- First Posted Date
- 2015-05-06
- Last Posted Date
- 2015-05-06
- Lead Sponsor
- Kineta Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02435342
- Locations
- 🇨🇦
Innovaderm Research, Inc, Montreal, Quebec, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath